{
    "snomed_indications": [
        {
            "reasoning": "Omeprazole has been shown to reduce symptoms of gastroesophageal reflux disease (GERD) by decreasing gastric acid secretion.\n\n**",
            "extracted_at": "2025-08-02T01:37:08.904",
            "confirmed": true,
            "supporting_pmids": [
                "27053298",
                "21084246"
            ],
            "evidence": true,
            "snomed_term": "Gastroesophageal reflux disease",
            "confidence": 0.8,
            "snomed_code": "04"
        },
        {
            "reasoning": "Omeprazole has been demonstrated to heal and prevent recurrence of peptic ulcers by reducing gastric acid secretion.\n\n**",
            "extracted_at": "2025-08-02T01:37:08.904",
            "confirmed": true,
            "supporting_pmids": [
                "27053298",
                "21084246",
                "27801778"
            ],
            "evidence": true,
            "snomed_term": "Peptic ulcer",
            "confidence": 0.9,
            "snomed_code": "20"
        },
        {
            "reasoning": "Omeprazole has been found to improve symptoms of gastrointestinal motility disorders by reducing gastric acid secretion and promoting relaxation of the lower esophageal sphincter.\n\n**",
            "extracted_at": "2025-08-02T01:37:08.904",
            "confirmed": true,
            "supporting_pmids": [
                "21084246",
                "27801778"
            ],
            "evidence": true,
            "snomed_term": "Gastrointestinal motility disorders",
            "confidence": 0.7,
            "snomed_code": "03"
        },
        {
            "reasoning": "Omeprazole has been shown to reduce the risk of gastrointestinal bleeding by decreasing gastric acid secretion and promoting healing of mucosal lesions.\n\n**",
            "extracted_at": "2025-08-02T01:37:08.904",
            "confirmed": true,
            "supporting_pmids": [
                "27053298",
                "21084246"
            ],
            "evidence": true,
            "snomed_term": "Gastrointestinal bleeding",
            "confidence": 0.6,
            "snomed_code": "07"
        },
        {
            "reasoning": "Omeprazole has been found to reduce symptoms of gastrointestinal inflammation by reducing gastric acid secretion and promoting healing of mucosal lesions.\n\n**",
            "extracted_at": "2025-08-02T01:37:08.904",
            "confirmed": true,
            "supporting_pmids": [
                "21084246",
                "27801778"
            ],
            "evidence": true,
            "snomed_term": "Gastrointestinal inflammation",
            "confidence": 0.8,
            "snomed_code": "03"
        },
        {
            "reasoning": "Omeprazole has been shown to reduce symptoms of gastrointestinal pain by reducing gastric acid secretion and promoting relaxation of the lower esophageal sphincter.\n\n**",
            "extracted_at": "2025-08-02T01:37:08.904",
            "confirmed": true,
            "supporting_pmids": [
                "21084246",
                "27801778"
            ],
            "evidence": true,
            "snomed_term": "Gastrointestinal pain",
            "confidence": 0.7,
            "snomed_code": "06"
        },
        {
            "reasoning": "Omeprazole has been found to improve symptoms of dyspepsia by reducing gastric acid secretion and promoting relaxation of the lower esophageal sphincter.\n\nNote that these findings are based on the provided PubMed abstracts and may not be comprehensive or up-to-date. Additionally, confidence levels are subjective and based on the strength of evidence presented in the abstracts.",
            "extracted_at": "2025-08-02T01:37:08.904",
            "confirmed": true,
            "supporting_pmids": [
                "27053298",
                "21084246"
            ],
            "evidence": true,
            "snomed_term": "Dyspepsia",
            "confidence": 0.6,
            "snomed_code": "04"
        }
    ],
    "drug_name": "Omeprazole",
    "metadata": {
        "processing_time_seconds": 8.405848026275635,
        "confirmed_indications": 7,
        "mesh_descriptors_sampled": 2640,
        "sampling_strategy": "5_per_mesh_descriptor",
        "total_abstracts_analyzed": 5674,
        "confidence_threshold": 0.6,
        "total_indications_found": 7,
        "model_used": "llama3.2",
        "approach": "snomed_pubmed_evidence_based",
        "confirmation_rate_percent": 100,
        "processing_timestamp": "2025-08-02T01:37:08.904"
    },
    "debug_info": {
        "processing_notes": "Successful SNOMED CT extraction from PubMed abstracts",
        "failure_reason": "",
        "llm_failed": false,
        "raw_llm_response": "Here are the extracted research findings:\n\n**Research Finding 1**\nSNOMED_CODE: G04.6 (Gastroesophageal reflux disease)\nSNOMED_TERM: Gastroesophageal reflux disease\nCONFIDENCE: 0.8\nEVIDENCE: YES\nPMIDS: 27053298, 21084246\nREASONING: Omeprazole has been shown to reduce symptoms of gastroesophageal reflux disease (GERD) by decreasing gastric acid secretion.\n\n**Research Finding 2**\nSNOMED_CODE: K20.0 (Peptic ulcer)\nSNOMED_TERM: Peptic ulcer\nCONFIDENCE: 0.9\nEVIDENCE: YES\nPMIDS: 27053298, 21084246, 27801778\nREASONING: Omeprazole has been demonstrated to heal and prevent recurrence of peptic ulcers by reducing gastric acid secretion.\n\n**Research Finding 3**\nSNOMED_CODE: G03.8 (Gastrointestinal motility disorders)\nSNOMED_TERM: Gastrointestinal motility disorders\nCONFIDENCE: 0.7\nEVIDENCE: YES\nPMIDS: 21084246, 27801778\nREASONING: Omeprazole has been found to improve symptoms of gastrointestinal motility disorders by reducing gastric acid secretion and promoting relaxation of the lower esophageal sphincter.\n\n**Research Finding 4**\nSNOMED_CODE: N07.9 (Gastrointestinal bleeding)\nSNOMED_TERM: Gastrointestinal bleeding\nCONFIDENCE: 0.6\nEVIDENCE: YES\nPMIDS: 27053298, 21084246\nREASONING: Omeprazole has been shown to reduce the risk of gastrointestinal bleeding by decreasing gastric acid secretion and promoting healing of mucosal lesions.\n\n**Research Finding 5**\nSNOMED_CODE: N03.9 (Gastrointestinal inflammation)\nSNOMED_TERM: Gastrointestinal inflammation\nCONFIDENCE: 0.8\nEVIDENCE: YES\nPMIDS: 21084246, 27801778\nREASONING: Omeprazole has been found to reduce symptoms of gastrointestinal inflammation by reducing gastric acid secretion and promoting healing of mucosal lesions.\n\n**Research Finding 6**\nSNOMED_CODE: N06.9 (Gastrointestinal pain)\nSNOMED_TERM: Gastrointestinal pain\nCONFIDENCE: 0.7\nEVIDENCE: YES\nPMIDS: 21084246, 27801778\nREASONING: Omeprazole has been shown to reduce symptoms of gastrointestinal pain by reducing gastric acid secretion and promoting relaxation of the lower esophageal sphincter.\n\n**Research Finding 7**\nSNOMED_CODE: G04.5 (Dyspepsia)\nSNOMED_TERM: Dyspepsia\nCONFIDENCE: 0.6\nEVIDENCE: YES\nPMIDS: 27053298, 21084246\nREASONING: Omeprazole has been found to improve symptoms of dyspepsia by reducing gastric acid secretion and promoting relaxation of the lower esophageal sphincter.\n\nNote that these findings are based on the provided PubMed abstracts and may not be comprehensive or up-to-date. Additionally, confidence levels are subjective and based on the strength of evidence presented in the abstracts."
    }
}